BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10805354)

  • 1. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.
    Skopouli FN; Dafni U; Ioannidis JP; Moutsopoulos HM
    Semin Arthritis Rheum; 2000 Apr; 29(5):296-304. PubMed ID: 10805354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
    Ioannidis JP; Vassiliou VA; Moutsopoulos HM
    Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
    Theander E; Manthorpe R; Jacobsson LT
    Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study.
    Yazisiz V; Göçer M; Erbasan F; Uçar İ; Aslan B; Oygen Ş; Gökalp Gök E; Terzioğlu ME
    Clin Rheumatol; 2020 Jan; 39(1):233-241. PubMed ID: 31555987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in Sjögren's syndrome.
    Voulgarelis M; Tzioufas AG; Moutsopoulos HM
    Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S66-71. PubMed ID: 19026146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies.
    Singh AG; Singh S; Matteson EL
    Rheumatology (Oxford); 2016 Mar; 55(3):450-60. PubMed ID: 26412810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome.
    Cafaro G; Perricone C; Carubbi F; Baldini C; Quartuccio L; Priori R; Berardicurti O; Ferro F; Gandolfo S; Gattamelata A; Giacomelli R; De Vita S; Gerli R; Bartoloni E
    Front Immunol; 2021; 12():615656. PubMed ID: 33841398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni E; Carubbi F; Gregoraci G; Gandolfo S; Salvin S; Luciano N; Minniti A; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Scand J Rheumatol; 2015; 44(1):36-41. PubMed ID: 25268749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.
    Goules AV; Tatouli IP; Moutsopoulos HM; Tzioufas AG
    Arthritis Rheum; 2013 Nov; 65(11):2945-53. PubMed ID: 24166794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ; Kelder JC
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.
    Argyropoulou OD; Pezoulas V; Chatzis L; Critselis E; Gandolfo S; Ferro F; Quartuccio L; Donati V; Treppo E; Bassoli CR; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos TE; Mavragani CP; Baldini C; Skopouli FN; Galli M; Fotiadis DΙ; De Vita S; Moutsopoulos HM; Tzioufas AG; Goules AV
    Semin Arthritis Rheum; 2020 Oct; 50(5):846-853. PubMed ID: 32896698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.
    Kim HJ; Kim KH; Hann HJ; Han S; Kim Y; Lee SH; Kim DS; Ahn HS
    Semin Arthritis Rheum; 2017 Oct; 47(2):222-227. PubMed ID: 28729155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
    Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
    Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.
    Maciel G; Crowson CS; Matteson EL; Cornec D
    Mayo Clin Proc; 2017 May; 92(5):734-743. PubMed ID: 28389066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
    Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
    Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.